Recruiting Heart Attack Studies in Lyon
KRT-232 and TKI Study in Chronic Myeloid Leukemia
This study evaluates KRT-232, a novel oral small molecule inhibitor of MDM2, for the treatment of patients with Ph+ Chronic Myeloid Leukemia (CML) who have relapsed or are refractory or intolerant to ...
Ribociclib (LEE011) Rollover Study for Continued Access
This study is to allow continued use of ribociclib (LEE011) as single agent or in combination with other investigational treatments in patients benefitting from treatment in an eligible Novartis-spons...
About Heart Attack Clinical Trials in Lyon
A heart attack (myocardial infarction) occurs when blood flow to part of the heart muscle is blocked, usually by a blood clot. It is a medical emergency requiring immediate treatment. Long-term management includes medications, lifestyle changes, and cardiac rehabilitation.
There are currently 2 heart attack clinical trials recruiting participants in Lyon, . These studies are seeking a combined 159 participants. Research is being sponsored by Kartos Therapeutics, Inc., Novartis Pharmaceuticals. Clinical trial participation is free and participants receive study-related medical care at no cost.
Heart Attack Clinical Trials in Lyon — FAQ
Are there heart attack clinical trials in Lyon?
Yes, there are 2 heart attack clinical trials currently recruiting in Lyon, . Browse the studies on this page to find one that fits.
How do I join a clinical trial in Lyon?
Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Lyon research site will contact you about next steps.
Are clinical trials in Lyon free?
Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Lyon studies also compensate for your time and travel.
What heart attack treatments are being tested?
The 2 active trials in Lyon are testing new therapies including novel drugs, biologics, and treatment approaches for heart attack.
Data updated March 2, 2026 from ClinicalTrials.gov